Advertisement

Mohs Micrographic Surgery for Melanoma

Evidence, Controversy, and a Critical Review of Excisional Margin Guidelines
  • David G. Brodland
    Correspondence
    5200 Centre Avenue, Suite 303, Pittsburgh, PA 15232.
    Affiliations
    Department of Dermatology, University of Pittsburgh

    Department of Otolaryngology, University of Pittsburgh

    Department of Plastic Surgery, University of Pittsburgh

    Z & B Skin Cancer Center, Pittsburgh PA
    Search for articles by this author
Published:October 27, 2022DOI:https://doi.org/10.1016/j.det.2022.07.008

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Dermatologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mohs F.E.
        Chemosurgical treatment of melanoma; a microscopically controlled method of excision.
        Arch Dermatol Symphilol. 1950; 62: 269-279
        • Snow S.N.
        • Mohs F.E.
        • Oriba H.A.
        • et al.
        Cutaneous malignant melanoma treated by Mohs surgery review of the treatment results of 179 cases from the Mohs melanoma registry.
        Dermatol Surg. 1997; 23: 1055-1060
        • Bienert T.N.
        • Trotter M.J.
        • Arlette J.P.
        Treatment of cutaneous melanoma of the face by Mohs micrographic surgery.
        J Cutan Med Surg. 2003; 7: 25-30
        • Bhardwaj S.S.
        • Tope W.D.
        • Lee P.K.
        Mohs micrographic surgery for lentigo maligna and Lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience.
        Dermatol Surg. 2006; 32 ([discussion: 96-7]): 690-696
        • Etzkorn J.R.
        • Sobanko J.F.
        • Elenitsas R.
        • et al.
        Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
        J Am Acad Dermatol. 2015; 72: 840-850
        • Stigall L.E.
        • Brodland D.G.
        • Zitelli J.A.
        The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
        J Am Acad Dermatol. 2016; 75: 1015-1021
        • Zalla M.J.
        • Lim K.K.
        • Dicaudo D.J.
        • et al.
        Mohs micrographic excision of melanoma using immunostains.
        Dermatol Surg. 2000; 26: 771-784
        • Valentin-Nogueras S.M.
        • Brodland D.G.
        • Zitelli J.A.
        • et al.
        Mohs micrographic surgery using MART-1 immunostain in the treatment of invasive melanoma and melanoma in situ.
        Dermatol Surg. 2016; 42: 733-744
        • Zitelli J.A.
        • Brown C.D.
        • Hanusa B.H.
        Surgical margins for excision of primary cutaneous melanoma.
        J Am Acad Dermatol. 1997; 37: 422-429
        • Demer A.M.
        • Vance K.K.
        • Cheraghi N.
        • et al.
        Benefit of Mohs micrographic surgery over wide local excision for melanoma of the head and neck: a rational approach to treatment.
        Dermatol Surg. 2019; 45: 381-389
        • Theunissen C.C.W.
        • Lee M.H.
        • Murad F.G.
        • et al.
        Systematic review of the role of Mohs micrographic surgery in the management of early-stage melanoma of the head and neck.
        Dermatol Surg. 2021; 47: 1185-1189
        • Pride R.L.D.
        • Miller C.J.
        • Murad M.H.
        • et al.
        Local recurrence of melanoma is higher after wide local excision versus Mohs micrographic surgery or staged excision: A systemic review of meta-analysis.
        Dermatol Surg. 2022; 48: 164-170
        • Swetter S.M.
        • Tsao H.
        • Wyatt S.
        • et al.
        Guidelines of care for the management of primary cutaneous melanoma.
        J Am Acad Dermatol. 2018; 80: 208-250
      1. National comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: melanoma (version 2.2022. January 26, 2022.

        • Veronesi U.
        • Cascinelli N.
        • Adamus J.
        • et al.
        Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.
        N Engl J Med. 1988; 318: 1159-1162
        • Veronesi U.
        • Cascinelli N.
        Narrow Excision (1-cm margin). A safe procedure for thin cutaneous melanoma.
        Arch Surg. 1991; 126: 438-441
        • Cohn-Cedermark G.
        • Rutqvist L.E.
        • Andersson R.
        • et al.
        Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm.
        Cancer. 2000; 89: 1495-1501
        • Balch C.M.
        • Soong S.J.
        • Smith T.
        • et al.
        Long-term results of a prospective surgical trial comparing 2 cm vs 4 cm excision margins for 740 patients with 1-4 mm melanomas.
        Ann Surg Oncol. 2001; 8: 101-108
        • Khayat D.
        • Rixie O.
        • Martin G.
        • et al.
        French Group of Research on Malignant Melanoma. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1 mm thick).
        Cancer. 2003; 97: 1941-1946
        • Thomas J.M.
        • Newton-Bishop J.
        • A’Hern R.
        • et al.
        Excisions Margins in high risk malignant melanoma.
        N Engl J Med. 2004; 350: 757-766
        • Hayes A.J.
        • Maynard L.
        • Coombes G.
        • et al.
        Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomized trial.
        Lancet Oncol. 2016; 17: 184-192
        • Gillgren P.
        • Drzewiecki K.T.
        • Niin M.
        • et al.
        2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomized, multicentre trial.
        Lancet. 2011; 378: 1635-1642
        • Utjes D.
        • Malmstedt J.
        • Teras J.
        • et al.
        2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomized trial.
        Lancet. 2019; 394: 471-477
        • Kunishige J.H.
        • Brodland D.G.
        • Zitelli J.A.
        Surgical margins for melanoma in situ.
        J Am Acad Dermatol. 2012; 66: 438-444
        • Trofymenko O.
        • Bordeaux J.S.
        • Zeitouni N.C.
        • et al.
        Melanoma of the face and Mohs micrographic surgery: nationwide mortality data analysis.
        Dermatol Surg. 2018; : 481-492
        • Bittar P.G.
        • Bittar J.M.
        • Etzkorn J.R.
        • et al.
        Systemic review and meta-analysis of local recurrence rates of head and neck cutaneous melanomas after wide local excision, Mohs micrographic surgery, or staged excision.
        Dermatol Surg. 2021; 85: 681-692
        • Urist M.M.
        • Balch C.M.
        • Soong S.J.
        • et al.
        The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma.
        Cancer. 1985; 55: 1398-1402
        • O’Brien C.J.
        • Coates A.S.
        • Peterson-Schaefer K.
        • et al.
        Experience with 998 cutaneous melanomas of the head and neck over 30 years.
        Am J Surg. 1991; 162: 310-314
        • Anderson A.P.
        • Gottlieb J.
        • Drzewlecki K.T.
        • et al.
        Skin melanoma of the head and neck. Prognostic factors and recurrence-free survival in 512 patients.
        Cancer. 1992; 69: 1153-1156
        • Rawlani R.
        • Rawlani V.
        • Qureshi H.A.
        • et al.
        Reducing Margins of Wide Local excision in hand and neck melanoma for function and cosmesis: 5-Year local recurrence free survival.
        J Surg Oncol. 2015; 111: 795-799
        • Sullivan S.
        • Liu D.Z.
        • Mathes D.W.
        • et al.
        Head and neck malignant melanoma: local recurrence rate following wide local excision and immediate reconstruction.
        Ann Plast Surg. 2012; 68: 33-36
        • Goldsmith L.A.
        • Askin F.B.
        • Chang A.E.
        • et al.
        Nation Institutes of Health Consensus Development Conference statement on diagnosis and treatment of early melanoma.
        Am J Dermatopathol. 1993; 15: 34-43
        • Abide J.M.
        • Nahai F.
        • Bennett R.G.
        The meaning of surgical margins.
        Plast Reconstr Surg. 1984; 73 (Evidence-Based Procedural Dermatology. Second Edition): 492-497
        • Panther D.
        • Brodland D.G.
        Invasive melanoma.
        Springer Nature, Switzerland AG2012: 1095
        • Bricca G.M.
        • Brodland D.G.
        • Zitelli J.A.
        Immunostaining melanoma frozen sections: the one hour protocol.
        Dermatol Surg. 2004; 30: 403-408
        • Hendi A.
        • Brodland D.G.
        • Zitelli J.A.
        Melanocytes in longstanding sun-exposed skin.
        Arch Dermatol. 2006; 142: 871-876
        • Balch C.M.
        Microscopic satellites around a primary melanoma: another piece of the puzzle in melanoma staging.
        Ann Surg Oncol. 2009; 16: 1092-1094
        • Ross M.I.
        • Balsh C.M.
        Excision margins of melanoma make a difference: new data support an old paradigm.
        Ann Surg Oncol. 2016; 23: 1053-1056
        • Brodland D.G.
        • Zitelli J.A.
        Mechanisms of metastasis.
        J Am Acad Dermatol. 1992; 27: 1-8
        • Poste G.
        • Fider I.J.
        The pathogenesis of cancer metastasis.
        Nature. 1980; 283: 1139-1146
        • Weiss L.
        • Harlos J.P.
        • Elkin G.
        • et al.
        Mechanisms for the biomechanical destruction of L1210 leukemia cells: a rate regulator for metastasis.
        Cell Biophys. 1990; 16: 149-159
        • Fidler I.J.
        • Gersten D.M.
        • Hart I.R.
        The biology of cancer invasion and metastasis.
        Adv Cancer Res. 1978; 28: 149-250
        • Poste G.
        Experimental systems for analysis of malignant phenotype.
        Cancer Metastasis Rev. 1982; 1: 141-199
        • Welch H.G.
        • Gorski D.H.
        • Albertsen P.C.
        Trends in metastatic breast and prostate cancer – lessons in cancer dynamics.
        N Engl J Med. 2015; 373: 18 1685-1687
        • Hellman S.
        Natural history of small breast cancers.
        J Clin Oncol. 1994; 12: 2229-2234
        • Bricca G.M.
        • Brodland D.G.
        • Ren D.
        • et al.
        Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
        J Am Acad Dermatol. 2005; 52: 92-100
        • Demer A.M.
        • Hanson J.L.
        • Maher I.A.
        • et al.
        Association of Mohs micrographic surgery vs wide local excision with overall survival outcomes for patients with melanoma of the trunk and extremities.
        JAMA Dermatol. 2021; 157: 84-89
        • Hanson J.
        • Demer A.
        • Liszewski W.
        • et al.
        Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide location excision.
        J Am Acad Dermatol. 2019; 82: 149-155
        • Burnett M.E.
        • Brodland D.G.
        • Zitelli J.A.
        Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal extremities.
        J Am Acad Dermatol. 2020; 84: 1-8
        • Degesys C.A.
        • Powell H.B.
        • Hsia L.B.
        • et al.
        Outcomes for invasive melanomas treated with Mohs micrographic surgery: a retrospective cohort study.
        Dermatol Surg. 2019; 45: 223-228
        • Namin A.W.
        • Oudin E.M.
        • Tassone P.T.
        • et al.
        Treatment of cutaneous melanoma of the head and neck with wide local excision versus Mohs.
        Laryngoscope. 2021; 131: 2490-2496
        • Bednar E.D.
        • Zon M.
        • Abu-Hilal M.
        Morbidity and mortality of melanoma on the trunk and extremities treated with Mohs surgery versus wide excision: A systematic review.
        Dermatol Surg. 2022; 48: 1-6
        • Niebling M.G.
        • Haydu L.E.
        • Lo S.N.
        • et al.
        The prognostic significance of microsatellites in cutaneous melanoma.
        Mod Pathol. 2020; 13: 1369-1379
        • Rzepecki A.K.
        • Hwang C.D.
        • Etzkorn J.R.
        • et al.
        The rule of 10s versus the rule of 2s: high complication rates after conventional excision with postoperative margin assessment of specialty site versus trunk and proximal extremity melanomas.
        J Am Acad Dermatol. 2021; 85: 442-452
        • DeBloom J.R.
        • Zitelli J.A.
        • Brodland D.G.
        The invasive growth potential of residual melanoma and melanoma in situ.
        Dermatol Surg. 2010; 36: 1251-1257
        • Etzkorn J.R.
        • Tuttle S.D.
        • Lim I.
        • et al.
        Patients prioritize local recurrence risk over other attributes for surgical treatment of facial melanomas – Results of a stated preference survey and choice-based conjoint analysis.
        J Am Acad Dermatol. 2018; 79: 210-219
        • Handley W.S.
        The pathology of melanotic growths in relation to their operative treatment.
        Lancet. 1907; 1: 996-1003